Executive Summary
For market researchers supporting pre-launch pharmaceutical brands, unbranded disease state education (DSE) campaigns represent a critical opportunity to shape the future market landscape. By raising disease awareness, educating healthcare providers (HCPs) and patients about unmet needs, and establishing a favorable lexicon around new treatments, effective DSE campaigns can help condition the market for successful launches. However, researchers must navigate several challenges in designing studies that yield actionable insights while avoiding common pitfalls. This white paper examines the strategic role of DSE research, market research benchmarks, best practices for message and creative optimization, and ZoomRx's proven approach for driving campaign impact.
The Role of Unbranded Education in Pre-Launch Strategy
For pharmaceutical brands introducing novel mechanisms of action or facing entrenched market misperceptions, unbranded campaigns can provide a powerful pre-launch tactic for shaping HCP and patient mindsets. While not appropriate for every launch, these campaigns can serve several strategic objectives:
1. Raising disease awareness and improving diagnosis rates
2. Educating HCPs and patients on unmet needs
3. Establishing a scientific narrative around new MOAs
4. Providing patient support and educational tools
5. Announcing future brand entry through "coming soon" messaging
By achieving these objectives, DSE campaigns establish favorable conditions for branded launch. ZoomRx's benchmarking suggests that about one-half to two-thirds of launch brands employ DSE campaigns, typically beginning 1 – 2 years before launch.
Messaging Research Benchmarks
According to ZoomRx's launch insights benchmarking data, unbranded message testing serves as a critical component of DSE campaign development, with 68% of benchmarked launch brands investing in this research. Message research typically begins an average of 23 months prior to launch, reflecting its strategic importance in shaping the scientific narrative. While HCPs are included in most message testing initiatives, only 33% of studies also explore patient perspectives. The average investment in US-based message testing ranges typically from $150,000-$200,000, enabling robust exploration of core communications pillars.
Creative Testing Benchmarks
Creative concept evaluation represents another key pillar of DSE research, with 58% of benchmarked launch brands investing in this area. Creative research typically begins slightly later than messaging, around 20 months pre-launch on average. The clear majority (89%) of creative testing initiatives employ qualitative methodologies, reflecting the importance of nuanced feedback in optimizing visual assets. For US-based studies, average creative research investment typically ranges from $140,000-$200,000, underscoring the critical importance of getting the executional elements right.
Common Challenges and Pitfalls in DSE Research
Market researchers face several obstacles in designing effective DSE research:
1. Navigating Regulatory Complexities: Each organization has its own medical-legal risk tolerance for unbranded campaigns. Partnering closely with compliance teams is critical to ensure research strikes the right balance between education and promotion.
2. Lack of Strategic Context: Without clear objectives, research respondents often default to inappropriate branded endpoints like prescribing intent. Establishing strategic success criteria upfront is key.
3. Inappropriate KPIs: Standard message assessments like preference or relevance can fail to capture the deeper mindset shifts effective DSE campaigns produce. Research must align KPIs with strategic campaign objectives.
4. Overly Rational Evaluations: The most impactful disease education campaigns often challenge entrenched beliefs in disruptive ways. Assessing them on rational attributes alone in market research can lead to suboptimal creative decisions.
5. Inadequate Narrative Focus: Evaluating messages in isolation risks losing sight of the overall narrative arc. Research must pressure-test the flow and cumulative impact of the holistic disease education narrative.
ZoomRx's Best-Practice Approach
ZoomRx's research methodology directly addresses these common pitfalls:
1. Stakeholder Partnership: Early alignment with insights, brand and compliance teams builds strategic guardrails into research design from the start. Proactive collaboration maximizes insights while ensuring alignment with regulatory needs. ZoomRx works hand-in-hand with the brand team, creative agency and medical-legal compliance stakeholders to pressure-test stimuli and craft appropriate research instruments. This partnership ensures the final recommendations are implementable within each organization's regulatory guardrails.
2. Grounding in Strategy: Extensive immersion in brand strategy, lexicon, and success criteria ensures research evaluates campaign elements against the right objectives. ZoomRx begins every DSE engagement with an immersion phase to align on current mindsets, desired shifts, and metrics of success. These strategic inputs serve as the North Star for research design, keeping the study laser-focused on the right goals.
3. Custom Campaign KPIs: We ensure that KPIs go beyond stated preference to assess deeper conviction, emotional impact, and behavioral intent. Rather than defaulting to standard message assessments, ZoomRx develops bespoke metrics in close partnership with brand teams and creative agency stakeholders.
4. Behavioral Science Lens: Recognizing that rational responses don't always predict real-world impact, ZoomRx's frameworks blend conscious and subconscious evaluation. Measuring intuitive responses is key to selecting truly impactful campaigns. Grounded in the latest behavioral science, ZoomRx's research incorporates techniques to help uncover the deeper subconscious impact of campaign elements.
5. Narrative-Driven Design: Pressure-testing the narrative flow and cumulative impact is as critical as individual message evaluation. ZoomRx's research unfolds messaging in a cohesive arc to simulate real-world campaign communications. These narrative-focused methodologies ensure the campaign conveys a compelling, cohesive story.
Optimizing DSE Messaging and Creative: A Phased Approach
Whenever launch timelines and budget allow, ZoomRx recommends a structured research process across three distinct phases.
1. Message Testing: Qualitative exploration pressure-tests potential DSE messaging territories and identifies the most compelling concepts, lexicon, and flow. Additional quantitative research is recommended to prioritize messages and quantify impact on KPIs. The combination of qualitative and quantitative research prioritizes messages that shift beliefs and establishes desired behaviors.
2. Creative Optimization: Iterative qualitative research assesses visual concepts on strategic KPIs like stopping power and emotional impact. Concept evaluation goes beyond preference to uncover deeper subconscious reactions.
3. In-Market Tracking: Multi-modal monitoring through tracking surveys, digital exposure tracking and social listening help to assess campaign impact in the real world. Tying DSE tracking to the broader launch roadmap ensures strategic integration and enables course-correction prior to launch.
Conclusion
For market researchers, unbranded disease education campaigns represent a powerful tool for shaping pre-launch landscapes. But capturing this opportunity requires a rigorous strategic approach grounded in clear objectives, rigorous methodology, and narrative-driven design. By adapting proven research frameworks to the unique challenges of unbranded campaigns, researchers can deliver insights that shift mindsets, drive key behaviors, and establish winning campaigns. As a trusted partner to pre-launch brands, ZoomRx brings deep expertise and a track record of impact to every DSE research engagement.
Get in touch with us:
